Carbapenem-resistant Pseudomonas aeruginosa: Factors influencing multidrug-resistant acquisition in non-critically ill patients

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 28, Issue 5, 2009, Pages 519-522

  Pena C ^a   Suarez, C ^a   Tubau, F ^a   Dominguez, A ^a   Sora, M ^a   Pujol, M ^a   Gudiol, F ^a   Ariza, J ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; GLYCOPEPTIDE; QUINOLONE DERIVATIVE;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; COHORT ANALYSIS; FEMALE; HUMAN; ISOLATION PROCEDURE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK FACTOR; URINARY CATHETER;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CATHETERS, INDWELLING; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; FLUOROQUINOLONES; HOSPITALS; HUMANS; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RISK FACTORS;

EID: 67349083918     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0645-9     Document Type: Article

References (16)

1. DM Livermore 2002 Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 34 634 640 (Pubitemid 34165326)
2. E Paramythiotou JC Lucet JF Timsit D Vanjak C Paugam-Burtz JL Trouillet 2004 Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity Clin Infect Dis 38 670 677 (Pubitemid 38333863)
3. S Nseir C Di Pompeo S Soubrier P Delour H Lenci M Roussel-Delvallez 2005 First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit Crit Care Med 33 283 289 (Pubitemid 40216539)
4. ME Falagas PK Koletsi P Kopterides A Michalopoulos 2006 Risk factors for isolation of strains susceptible only to polymyxin among patients with Pseudomonas aeruginosa bacteremia Antimicrob Agents Chemother 50 2541 2543 (Pubitemid 43993200)
5. DL Paterson 2006 The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species Clin Infect Dis 43 S43 S48
6. ME Falagas P Kopterides 2006 Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature J Hosp Infect 64 7 15 (Pubitemid 44161380)
7. TP Lodise CD Miller J Graves JP Furuno JC [tmp] McGregor B Lomaestro 2007 Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance Antimicrob Agents Chemother 51 417 422 (Pubitemid 46185255)
8. C Peña A Guzmán C Suarez MA Dominguez F Tubau M Pujol 2007 Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients Antimicrob Agents Chemother 51 1967 1971 (Pubitemid 46903081)
9. G Aubert B Pozzetto G Dorche 1992 Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy J Antimicrob Chemother 29 307 312
10. SA Alyaseen KE Piper MS Rouse JM Steckelberg R Patel 2005 Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime Antimicrob Agents Chemother 49 2543 2545 (Pubitemid 40734502)
11. ME Charlson P Pompei KL Ales CR [tmp] MacKenzie 1987 A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 373 383 (Pubitemid 17055592)
12. ND Friedman KS Kaye JE Stout SA [tmp] McGarry SL Trivette JP Briggs 2002 Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections Ann Intern Med 137 791 797 (Pubitemid 35334450)
13. Clinical and Laboratory Standards Institute (formerly NCCLS) (2006) Performance standards for antimicrobial susceptibility testing: 16th informational supplement. CLSI document M100-S16. ISBN 1-56238-588-7. Clinical Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898, USA
14. ME Falagas PK Koletsi IA Bliziotis 2006 The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa J Med Microbiol 55 1619 1629 (Pubitemid 44902023)
15. K Poole 2000 Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria Antimicrob Agents Chemother 44 2233 2241 (Pubitemid 30650861)
16. J Kriengkauykiat E Porter O Lomovskaya A Wong-Beringer 2005 Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa Antimicrob Agents Chemother 49 565 570 (Pubitemid 40175663)